Viewing Study NCT00258050


Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2025-12-25 @ 2:34 PM
Study NCT ID: NCT00258050
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2005-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-11-21
Start Date Type: ACTUAL
Primary Completion Date: 2007-02-08
Primary Completion Date Type: ACTUAL
Completion Date: 2007-02-08
Completion Date Type: ACTUAL
First Submit Date: 2005-11-22
First Submit QC Date: None
Study First Post Date: 2005-11-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-12-04
Last Update Post Date: 2017-12-06
Last Update Post Date Type: ACTUAL